HomeStudiesA clinical trial assessing the safety and efficacy...NegativeClinical Trial2010A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose studyView StudyClassification ResultsAI ClassificationNegativeFine-tuned ClassificationN/AConditions StudiedObesityRelated StudiesPositive